Edition:
United Kingdom

DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

57.04USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$57.04
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
523,834
52-wk High
$88.80
52-wk Low
$42.63

Latest Key Developments (Source: Significant Developments)

Dexcom announces development agreement with Lilly
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Dexcom Inc ::Dexcom announces development agreement with Lilly to integrate Dexcom CGM into connected diabetes ecosystem.Says ‍companies expect to combine Lilly's smart insulin delivery devices and Dexcom CGM.  Full Article

Dexcom Inc reports Q3 GAAP loss per share $0.02
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Dexcom Inc :Dexcom, inc. Reports record third quarter 2017 financial results.Q3 non-gaap loss per share $0.04.Q3 gaap loss per share $0.02.Q3 revenue $184.6 million versus i/b/e/s view $184.2 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article

‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Tandem Diabetes Care Inc ::‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​.Tandem diabetes care inc - ‍tandem and Dexcom are now extending terms of their welcome programs for animas customers through march 31, 2018​.  Full Article

‍Janus Henderson reports 10.2 pct passive stake in Dexcom
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - ‍Janus Henderson Group PLC:‍Janus Henderson Group PLC reports a 10.2 percent passive stake in Dexcom Inc as of sept 30 - SEC filing​.  Full Article

Dexcom Inc Reports second quarter 2016 financial results
Tuesday, 2 Aug 2016 

Dexcom Inc : Q2 revenue $137.3 million versus I/B/E/S view $132.6 million . Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S . Dexcom, Inc. Reports second quarter 2016 financial results .Q2 GAAP loss per share $0.24.  Full Article

Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting
Tuesday, 19 Jul 2016 

Dexcom Inc : Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting .Dexcom Inc says clinical chemistry and clinical toxicology devices panel to convene on July 21.  Full Article

Dexcom to expand manufacturing operations to Greater Phoenix
Monday, 20 Jun 2016 

Dexcom Inc : Dexcom to expand manufacturing operations to Greater Phoenix, Arizona .Dexcom Inc says expect initial manufacturing operations in facility to commence in Q2 of 2017.  Full Article

Dexcom says entered into $200 mln revolving credit agreement
Monday, 20 Jun 2016 

Dexcom Inc : On june 17, entered into $200 million revolving credit agreement with jpmorgan chase bank, n.a., bank of america, silicon valley bank,union bank . Says as Of June 17, 2016, Dexcom had no outstanding loans under credit agreement - Sec filing . Credit agreement provides a subfacility of up to $10 million for letters of credit . Dexcom inc says credit agreement matures on june 17, 2021 . Credit agreement provides a $25 million sublimit for borrowings in canadian dollars, euros, british pounds, swedish krona, japanese yen .Has option to increase maximum principal amount available under credit agreement by up to an additional $100 million.  Full Article

BRIEF-Dexcom announces development agreement with Lilly

* Dexcom announces development agreement with Lilly to integrate Dexcom CGM into connected diabetes ecosystem